(R)-(+)-Rabeprazole sodium – (171440-18-9)

185449-81-4, 636559-56-3, (S)-4-(Dinaphtho[2, 1-d:1', 2'-f][1, 3, 2]dioxaphosphepin-4-yl)morpholine, (11bR)-4-(4-Morpholinyl)dinaphtho[2, 1-d:1', 2'-f][1, 3, 2]dioxaphosphepin, (S)-4-(Dinaphtho[2, 1-d:1', 2'-f][1, 3, 2]-dioxaphosphepin-4-yl)morpholine, Morpholine, 4-(11bR)-dinaphtho[2, 1-d:1', 2'-f][1, 3, 2]dioxaphosphepin-4-yl-, 4-(12, 14-dioxa-13-phosphapentacyclo[13.8.0.02, 11.03, 8.018, 23]tricosa-1(15), 2(11), 3, 5, 7, 9, 16, 18, 20, 22-decaen-13-yl)morpholine, (S)-MORFPHOS, 4-(12, 14-dioxa-13-phosphapentacyclo[13.8.0.0^{2, 11.0^{3, 8.0^{18, 23]tricosa-1(15), 2(11), 3, 5, 7, 9, 16, 18, 20, 22-decaen-13-yl)morpholine, SCHEMBL15422409, 4-(11bR)-Dinaphtho[2, 1-d, DTXSID50470890, 4-(Dinaphtho[2, 1-d:1', 2'-f][1, 3, 2]dioxaphosphepin-4-yl)morpholine, 4-(11bR)-Dinaphtho[2, 1-d:1', 2'-f][1, 3, 2]dioxaphosphepin-4-ylmorpholine, SY223948, CS-0085218, CS-0086853, E78668, F52256, 4-(4H-Dinaphtho[2, 1-d:1', 2'-f][1, 3, 2]dioxaphosphepin-4-yl)morpholine, (R)-4-(DINAPHTHO[2, 1-D:1', 2'-F][1, 3, 2]DIOXAPHOSPHEPIN-4-YL)MORPHOLINE, (S)-(+)-(3, 5-Dioxa-4-phospha-cyclohepta[2, 1-a 3, 4-a'']dinaphthalen-4-yl)morpholine, (S)-(+)-(3, 5-Dioxa-4-phosphacyclohepta[2, 1-a 3, 4-a']dinaphthalen-4-yl)morpholine, (S)-(+)-(3, 5-Dioxa-4-phosphacyclohepta[2, 1-a 3, 4-a']dinaphthalen-4-yl)morpholine, 97%, 4-?(11bR)?-Dinaphtho[2, ?1-?d:1', ?2'-?f]?[1, ?3, ?2]?dioxaphosphepin-?4-?ylmorpholine, 4-(11bR)-Dinaphtho[2 pound not1-d:1' pound not2'-f][1 pound not3 pound not2]dioxaphosphepin-4-ylmorpholine, 4-(11bS)-Dinaphtho[2 pound not1-d:1' pound not2'-f][1 pound not3 pound not2]dioxaphosphepin-4-ylmorpholine, 4-[(11bR)-Dinaphtho[2, 1-d:1 inverted exclamation mark, 2 inverted exclamation mark -f][1, 3, 2]dioxaphosphepin-4-yl]morpholine, 4-{12, 14-DIOXA-13-PHOSPHAPENTACYCLO[13.8.0.0(2), (1)(1).0(3), ?.0(1)?, (2)(3)]TRICOSA-1(15), 2(11), 3, 5, 7, 9, 16, 18, 20, 22-DECAEN-13-YL}MORPHOLINE